| Title |
Role of Patient and Disease Factors in Adjuvant Systemic Therapy Decision Making for Early-Stage, Operable Breast Cancer: Update of the ASCO Endorsement of the Cancer Care Ontario Guideline.
|
|---|---|
| Published in |
Journal of Clinical Oncology, June 2019
|
| DOI | 10.1200/jco.19.00948 |
| Pubmed ID | |
| Authors |
N Lynn Henry, Mark R Somerfield, Vandana G Abramson, Nofisat Ismaila, Kimberly H Allison, Carey K Anders, Diana T Chingos, Andrea Eisen, Bruno L Ferrari, Thomas H Openshaw, Patricia A Spears, Praveen Vikas, Vered Stearns |
X Demographics
The data shown below were collected from the profiles of 24 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 6 | 25% |
| Mexico | 2 | 8% |
| United Kingdom | 2 | 8% |
| Japan | 1 | 4% |
| Iraq | 1 | 4% |
| France | 1 | 4% |
| Venezuela, Bolivarian Republic of | 1 | 4% |
| Unknown | 10 | 42% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 17 | 71% |
| Practitioners (doctors, other healthcare professionals) | 4 | 17% |
| Scientists | 2 | 8% |
| Science communicators (journalists, bloggers, editors) | 1 | 4% |
Mendeley readers
The data shown below were compiled from readership statistics for 104 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 104 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 15 | 14% |
| Other | 11 | 11% |
| Student > Ph. D. Student | 8 | 8% |
| Student > Master | 8 | 8% |
| Student > Bachelor | 7 | 7% |
| Other | 17 | 16% |
| Unknown | 38 | 37% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 36 | 35% |
| Biochemistry, Genetics and Molecular Biology | 7 | 7% |
| Nursing and Health Professions | 5 | 5% |
| Agricultural and Biological Sciences | 3 | 3% |
| Pharmacology, Toxicology and Pharmaceutical Science | 2 | 2% |
| Other | 7 | 7% |
| Unknown | 44 | 42% |
Attention Score in Context
This research output has an Altmetric Attention Score of 18. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 October 2023.
All research outputs
#2,064,144
of 25,385,509 outputs
Outputs from Journal of Clinical Oncology
#4,950
of 22,054 outputs
Outputs of similar age
#43,746
of 367,213 outputs
Outputs of similar age from Journal of Clinical Oncology
#126
of 601 outputs
Altmetric has tracked 25,385,509 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 91st percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 22,054 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.0. This one has done well, scoring higher than 77% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 367,213 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 88% of its contemporaries.
We're also able to compare this research output to 601 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 79% of its contemporaries.